Question 1

What is the catalog number for Human TRIOBP knockout cell line?

Accepted Answer

The catalog number for Human TRIOBP knockout cell line is ABC-KH16138.

Question 2

What sizes are available for Human TRIOBP knockout cell line?

Accepted Answer

Human TRIOBP knockout cell line is available in the following size(s): 1 Vial.

Question 3

Is Human TRIOBP knockout cell line in stock?

Accepted Answer

Human TRIOBP knockout cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for Human TRIOBP knockout cell line?

Accepted Answer

Human TRIOBP knockout cell line is requires dry ice shipping.

Question 5

What is Human TRIOBP knockout cell line used for?

Accepted Answer

Human TRIOBP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 7

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 8

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Human TRIOBP knockout cell line

Product Specifications

Applications

Storage Conditions

Frequently Asked Questions

Explore Other Products

NFE2L2 (Nuclear Factor (erythroid-Derived 2)-like 2, NRF2) (MaxLight 550)

NFE2L2 (Nuclear Factor (erythroid-Derived 2)-like 2, NRF2) (MaxLight 550)

STK16 Human Over-expression Lysate

Vimentin (phospho Ser56) Polyclonal Antibody

Vimentin (phospho Ser56) Polyclonal Antibody

RASSF2 discontinued